Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix^® Assessment

Medidata PR
Medidata.PR@3ds.com

Analyst Relations
medidata.AR@3ds.com

Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix^® Assessment for Electronic Data Capture (EDC) in life sciences.

The report, which evaluated 20 providers, highlighted Medidata Rave EDC for its seamless integration with wearables, sensors, and EHRs, along with its advanced capabilities in source data verification, AI-driven query management, and adverse event handling. Rave EDC earned recognition for its intuitive, low-code design, enabling rapid implementation of protocol amendments, and simplifying the creation of electronic case report forms (eCRFs), while maintaining data quality and integrity for clinical trial sponsors.

“We are honored to be recognized as a Leader in EDC by Everest Group,” said Anthony Costello, CEO, Medidata. “Rave EDC, the industry gold standard, has led electronic data capture for decades. Given the constantly evolving healthcare landscape, we continue to innovate to meet the growing demands for decentralized trials, empowering sponsors to use real-time data and AI to drive innovation and efficiency in the development of life-saving treatments.”

The Everest Group report emphasized Medidata’s strong brand presence among large and mid-sized pharmaceutical companies and its extensive partnerships with CROs and clinical trial technology providers. This recognition reinforces Medidata’s leadership in driving the future of digital clinical trials.

For more information, visit our website.

About Medidata

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

About Dassault Systèmes

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all –consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com.

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240917798345/en/